J&J Unit Loses Out To Medtronic In Stent Case

Law360, New York (March 23, 2006, 12:00 AM EST) -- In a big upset for Johnson & Johnson, an arbitration panel has ruled that a Medtronic Inc. coronary stent does not infringe on its rival’s patents, giving Medtronic the opportunity to take a large bite out of the $5 billion global stent market.

The independent panel found Wednesday that Medtronic’s Driver stent did not violate a 1997 settlement and cross-license agreement with patents of Johnson & Johnson’s Cordis unit.

The arbitration panel found its devices were licensed under the agreement between Medtronic and Cordis for the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.